BioAmpMax

Glucose Disposal & Insulin Sensitivity

ATX-304 directly activates AMPK in liver and muscle, suppressing gluconeogenesis and potentiating insulin-stimulated glucose uptake—demonstrated by reduced fasting glucose and HOMA-IR in type 2 diabetic patients on metformin [1]. 5-Amino-1MQ, an NNMT inhibitor, boosted NAD⁺ in obese mice, leading to a ~50 % reduction in fasting insulin and improved glucose tolerance [2]. Myo-inositol supplementation (2 g/day) in humans lowers fasting insulin and HOMA-IR by ~2 points, with significant reductions in post-OGTT glucose excursions [3][6].

Lipid & Endothelial Support

5-Amino-1MQ–treated obese mice saw a ~30 % decrease in fat mass and normalization of cholesterol to lean levels without altering food intake, indicating enhanced fat oxidation [2]. Chromium picolinate (200–1000 µg) yields modest triglyceride and LDL-C reductions in insulin-resistant individuals [7][8]. NAC supplementation (1.2 g/day) in metabolic syndrome patients lowered hsCRP by ~13 %, reduced systolic blood pressure by 5 mmHg, and improved HDL levels, highlighting anti-inflammatory and endothelial benefits [9].

Mitochondrial & Energy Metabolism

ATX-304 functions as an exercise mimetic: in aged mice it enhanced cardiac output, microvascular perfusion, and exercise capacity—effects attributed to AMPK-driven mitochondrial biogenesis [1][2]. By inhibiting NNMT, 5-Amino-1MQ preserves NAD⁺ pools, activating sirtuin pathways that support mitochondrial function [2]. NAC’s antioxidative action protects mitochondrial integrity under metabolic stress, evidenced by normalized mitochondrial respiration in diabetic rodent models [9].

Inositol Signaling & Glycogen Synthesis

Myo-inositol acts as a secondary messenger in insulin pathways, improving insulin sensitivity across trials with fasting insulin and HOMA-IR reductions [3][6]. D-chiro-inositol at 1,200 mg/day for 6 weeks in insulin-resistant women lowered insulin AUC by ~60 % and restored ovulation in 86 % of subjects, demonstrating potent glycogen-synthesis and insulin-mimetic actions [5].

Redox Balance & Anti-inflammatory Support

NAC replenishes glutathione, mitigating oxidative stress underlying insulin resistance. In metabolic syndrome patients, 6 weeks of NAC (1,200 mg/day) reduced HOMA-IR by ~18 % and hsCRP by ~13 % [9].

References

1. AMPK activated protein kinase in T2D: https://pubmed.ncbi.nlm.nih.gov/29925691/
2. Age-related effects & obesity in mice: https://www.nature.com/articles/s41598-021-85051-6
3. JCI insight on liver disease & AMPK: https://insight.jci.org/articles/view/179990/
4. Obesity & ATX-304 in diet-induced obese mice: https://www.nature.com/articles/s42003-021-02837-0
5. D-chiro-inositol PCOS trial: https://pubmed.ncbi.nlm.nih.gov/10219066/
6. Myo-inositol glycemic effects: https://pmc.ncbi.nlm.nih.gov/articles/PMC8896029/
7. Chromium review (LPI): https://lpi.oregonstate.edu/mic/minerals/chromium
8. Chromium meta-analysis: https://pubmed.ncbi.nlm.nih.gov/32730903/
9. NAC in metabolic syndrome & inflammation:https://pubmed.ncbi.nlm.nih.gov/32552298/

Note: BioAmpMax is supplied strictly for investigational research use only. It is not approved or intended for diagnostic or therapeutic applications in humans or animals.